CM
NTLA icon

Caption Management’s Intellia Therapeutics NTLA Stock Holding History

Caption Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
+84,700
New +$1.19M 0.01% 1009
2026
Q1 		– Sell
-20,000
Closed -$255K – 1901
2025
Q4 		$180K Buy
20,000
+19,872
+15,525% +$274K ﹤0.01% 1391
2025
Q3 		$2.21K Sell
128
-12,548
-99% -$155K ﹤0.01% 1602
2025
Q2 		$119K Hold
12,676
– – ﹤0.01% 1308
2025
Q1 		$90.1K Sell
12,676
-42,324
-77% -$428K ﹤0.01% 1366
2024
Q4 		$641K Buy
55,000
+54,100
+6,011% +$844K 0.01% 1026
2024
Q3 		$18.5K Sell
900
-5,100
-85% -$118K ﹤0.01% 1207
2024
Q2 		$134K Sell
6,000
-9,616
-62% -$229K ﹤0.01% 997
2024
Q1 		$430K Buy
+15,616
New +$434K 0.01% 904
2023
Q4 		– Sell
-500
Closed -$14.4K – 1553
2023
Q3 		$15.8K Buy
+500
New +$19.4K ﹤0.01% 1219
2023
Q1 		– Sell
-1,550
Closed -$60.8K – 1396
2022
Q4 		$54.1K Sell
1,550
-12,056
-89% -$573K ﹤0.01% 1172
2022
Q3 		$762K Sell
13,606
-22,574
-62% -$1.4M 0.01% 959
2022
Q2 		$1.87M Buy
36,180
+31,880
+741% +$1.62M 0.03% 689
2022
Q1 		$312K Buy
4,300
+2,314
+117% +$196K ﹤0.01% 1206
2021
Q4 		$234K Buy
+1,986
New +$249K ﹤0.01% 1395
2021
Q2 		– Sell
-37,701
Closed -$2.94M – 1490
2021
Q1 		$3.03M Buy
+37,701
New +$2.53M 0.07% 393

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Caption Management's NTLA Position: Q2 2026 in Review

Caption Management opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 84,700 shares worth $1.43M. The stake represents 0.01% of the portfolio and ranks #1009 among its holdings. This is a return to the name: Caption Management previously reported a position in NTLA as recently as Q4 2025.

Caption Management first reported a position in NTLA in Q1 2021 and has held it in 16 quarters since. The position peaked at $3.03M in Q1 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Caption Management held 84,700 shares of Intellia Therapeutics worth $1.43M as of Q2 2026.
  • Intellia Therapeutics was a new Caption Management position in Q2 2026.
  • Intellia Therapeutics made up 0.01% of Caption Management's portfolio in Q2 2026, its #1009 holding.
  • Caption Management first reported a position in Intellia Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Caption Management's Intellia Therapeutics position peaked at $3.03M in Q1 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.